Related references
Note: Only part of the references are listed.THE STATISTICAL PERFORMANCE OF MATCHING-ADJUSTED INDIRECT COMPARISONS: ESTIMATING TREATMENT EFFECTS WITH AGGREGATE EXTERNAL CONTROL DATA
David Cheng et al.
ANNALS OF APPLIED STATISTICS (2020)
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
A. H. Wei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Maintenance therapy for AML: are we there yet?
Andrew H. Wei
BLOOD (2019)
Maintenance therapy in AML: The past, the present and the future
Matteo Molica et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients
Gerwin Huls et al.
BLOOD (2019)
Azacitidine for Post-Remission Therapy in Elderly Patients with Acute Myeloid Leukemia : Final Results of the Qoless AZA-Amle Randomized Trial
Esther Natalie Oliva et al.
BLOOD (2019)
Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
David M. Phillippo et al.
MEDICAL DECISION MAKING (2018)
Prognosis, Effect Modification, and Mediation
Andrew J. Vickers et al.
EUROPEAN UROLOGY (2018)
Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials
Armin Rashidi et al.
BLOOD (2016)
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Christopher R. Cogle et al.
ONCOLOGIST (2015)
Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies
Eric Laille et al.
PLOS ONE (2015)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Guillermo Garcia-Manero et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
David C. Hoaglin et al.
VALUE IN HEALTH (2011)
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia:: an Eastern Cooperative Oncology Group Trial (E5483)
C Robles et al.
LEUKEMIA (2000)
Share Paper
